Bevacizumab (Avastin) as a potential novel adjunct in the management of pterygia

INTRAVITREAL BEVACIZUMAB (AVASTIN) FOR PERSISTENT NEW VESSELS IN DIABETIC RETINOPATHY (IBEPE STUDY)

Rodrigo Jorge, Rogério A. Costa, Daniela Calucci et al. · Retina · 2006 · 258 citations

Medicine, Ophthalmology, Pharmacotherapy +17

Intravitreal Bevacizumab (Avastin®) in the Treatment of Neovascular Glaucoma

Milko E. Iliev, Diego Domig, Ute Wolf-Schnurrbursch et al. · American Journal of Ophthalmology · 2006 · 240 citations

Pharmacy, Ophthalmology, Pharmacotherapy +14

Inhibition of experimental corneal neovascularisation by bevacizumab (Avastin)

R. P A Manzano, Gholam A. Peyman, Palwasha Khan et al. · British Journal of Ophthalmology · 2006 · 221 citations · Full text

Medicine, Ophthalmology, Pharmacology +17

Histology of pterygium: an electron microscopic study.

M E Cameron · British Journal of Ophthalmology · 1983 · 139 citations · Full text

Medicine, Dermatology, Pathology +10

Expression of Vascular Endothelial Growth Factor and Inducible Nitric Oxide Synthase in Pterygia

Do‐Hyung Lee, Hye Jin Cho, Jong-Tak Kim et al. · Cornea · 2001 · 124 citations

Medicine, Ophthalmology, Surgery +14